rareLife solutions

Home
United States
Westport, CT
rareLife solutions

collaboration. science. technology. our collaborative teams benefit rare patients' lives by develop

08/18/2026

The future of cardiology is being shaped by connection, collaboration, and new possibilities.

At the ESC Congress 2026 in Munich, Laura Wuerth will be connecting with leaders and innovators exploring how AI, breakthrough data, and patient-centered care can transform cardiovascular health and translate innovation into real-world impact.

If you’ll be at ESC, meet with Laura and explore what’s next!

08/11/2026

August is Spinal Muscular Atrophy (SMA) Awareness Month, and rareLife solutions proudly supports the individuals, families, caregivers, advocates, clinicians, and researchers working to improve the lives of those affected by SMA.

SMA is a rare, progressive genetic neuromuscular disease caused by mutations in the SMN1 gene, resulting in a deficiency of the survival motor neuron (SMN) protein that is essential for healthy motor nerve cells. As these cells are lost, individuals with SMA experience progressive muscle weakness that can affect breathing, eating, sitting, crawling, walking, and other everyday activities.

SMA affects approximately 1 in 15,000 births in the United States, and 1 in 50 Americans is a genetic carrier. While advances in newborn screening and disease-modifying therapies have transformed the outlook for many individuals, continued awareness, research, early diagnosis, and access to care remain critical.

💜 It's also important to recognize that while SMA affects muscle function, it does not affect a person's intelligence, ability to learn, or capacity to build meaningful relationships. 💜

At rareLife solutions, we know rare. We think rare. And for us, it's personal. We are committed to advancing science, amplifying patient and caregiver voices, and supporting the communities driving progress across rare diseases.

This August, join us in raising awareness, inspiring understanding, and supporting a future where every person living with SMA has the opportunity to thrive.

Awareness drives understanding. Understanding drives action.

07/28/2026

Rare disease is complex—and so are the people living it. At rareLife solutions, we combine scientific expertise with a deep understanding of patients, caregivers, and communities to build solutions that improve outcomes and access.
Learn more at www.rarelifesolutions.com

07/21/2026

What if your biggest publication opportunity is the one no one has identified yet?

Rare disease publication strategy isn't about managing more—it's about uncovering what's missing.

mApIt combines AI with human intelligence (HI) to identify evidence gaps, uncover strategic opportunities, and build market-responsive publication programs that shape the rare disease landscape.

Ready to uncover what's missing? Schedule a demo today: https://loom.ly/wLWp2v0

06/24/2026

Today we celebrate Day and the power of medical communications to advance science, improve understanding, and connect communities.
In rare disease, every publication, presentation, patient story, and scientific exchange matters. Effective medical communications help accelerate awareness, reduce diagnostic delays, support informed decision-making, and bring the voices of patients with rare disease and caregivers into the conversation.
At rareLife solutions, we know rare. We think rare. And for us, it’s personal. We are proud to partner with industry, advocates, clinicians, and rare communities to turn complex science into meaningful impact.
Here’s to the professionals shaping the future of health care through science, strategy, and communication.

06/18/2026

We are proud to share that Mukund Nori, PhD, MBA, CMPP, Vice President, Medical & Scientific Affairs at rareLife solutions, has been appointed Editor-in-Chief of Future Rare Diseases.

This appointment reflects Mukund's longstanding commitment to advancing scientific excellence, publication ethics, and meaningful communication in rare disease. In addition to his extensive experience in medical and scientific affairs, Mukund previously served as Chair of the Ethics and Standards Committee for the International Society of Medical Publication Professionals (ISMPP), helping shape best practices across the industry.

As Editor-in-Chief, Mukund will help guide the future of a journal dedicated to increasing visibility, knowledge sharing, and collaboration across the rare disease community. Future Rare Diseases serves as an open-access platform for clinical and translational research, connecting scientists, clinicians, policymakers, patient advocates, and patients to accelerate progress in rare disease research and treatment development.

At rareLife solutions, we believe that advancing rare disease science requires strong leadership, scientific rigor, and a commitment to amplifying the voices of rare communities. We are thrilled to see Mukund bring those qualities to this important role.

Please join us in congratulating Mukund on this well-deserved achievement.

06/16/2026

We are honored to share that rareLife solutions has been recognized as the 2026 Outstanding Industry Partner by Purdue University Northwest (PNW).

This recognition reflects a partnership built on a shared commitment to innovation, learning, and addressing real-world challenges.

When developing mApIt, our AI-Powered Strategic Medical Publications Insights Tool, we adopted an academic-industry collaboration model and partnered with the PNW College of Technology. Through our collaboration with PNW, we gained access to exceptionally talented masters and doctoral students, as well as faculty expertise, including leadership from the College of Technology. In return, students gained hands-on, real-life experience developing a solution designed to address pressing needs in medical affairs and medical publications.

PNW's College of Technology works with more than 30 corporate and industry partners, making this recognition especially meaningful to our team.

At rareLife solutions, we believe that the best innovations emerge when diverse perspectives come together around a common goal. This partnership demonstrates the power of connecting academic talent with industry expertise to create solutions that can help advance the future of health care and scientific communications.

Thank you to the students, faculty, and leadership at PNW for being outstanding collaborators on this journey.

We know rare. We think rare. And we are proud to think differently.

https://loom.ly/e47fxFc

06/11/2026

Introducing mApIt: AI-Powered Strategic Medical Publications Insights Tool

At rareLife solutions, we know rare. We think rare. And we know that building a strategic rare disease publication program requires more than data; it requires insight.

That is why we created mApIt, a cutting-edge AI-powered application developed by rare disease medical publications experts to transform publication strategy development.

mApIt aggregates and analyzes indication-specific publications, clinical trials, journals, authors, and competitor data in minutes, replacing months of manual research and helping teams:

✅ Rapidly gather insights to inform publication strategy
✅ Identify opportunities to differentiate and strategically position programs
✅ Build market-responsive publication plans with greater confidence and efficiency

mApIt results combined with HI (human intelligence) transform information into actionable intelligence, helping teams spend less time searching and more time shaping impactful publication strategies.

People say rare is different. We agree. That is why we built a tool that thinks differently.

Contact us to schedule a demo to learn more about mApIt and accelerate your publication strategy: https://loom.ly/wLWp2v0

06/04/2026

rareLife solutions is heading to the World Orphan Drug Congress USA 2026.
Hugh Bartlett will be onsite in Boston from Tuesday, June 9 through Thursday, June 11, collaborating with innovators, advocates, and changemakers advancing rare disease research, drug development, and patient access.
We know rare. We think rare. And we believe strategic problem-solving drives meaningful progress.
If you will be at WODC, let’s connect.

05/22/2026

On World Neurofibromatosis Type 2 (NF2) Awareness Day, rareLife stands with individuals, families, caregivers, and advocates affected by this rare genetic disorder.
NF2 is characterized by slow-growing tumors that develop in the nervous system, most commonly vestibular schwannomas affecting hearing and balance. Individuals living with NF2 may also experience vision changes, tinnitus, weakness, pain, and other neurologic complications that can significantly affect daily life.
For rare communities, awareness matters. Earlier recognition, stronger research, multidisciplinary care, and continued innovation can help improve outcomes and quality of life for those navigating NF2.
At rareLife solutions, we know rare. We think rare. And for us, it’s personal. We are committed to advancing science, amplifying patient and caregiver voices, and supporting communities driving progress in rare disease.
Awareness drives understanding. Understanding drives action.

Address

606 Post Road East, #397
Westport, CT
06880

Telephone

+18446638642

Website

http://rareLifesolutions.com/

Alerts

Be the first to know and let us send you an email when rareLife solutions posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your establishment to be the top-listed Arts & Entertainment in Westport?